3.4400
+0.0200
+(0.58%)
At close: 5:35:28 PM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Kevin R. Helash | CEO & Executive Director | 380.46k | -- | 1965 |
| Mr. Douglas Minder | Chief Financial Officer | -- | -- | -- |
| Dr. Carlo Boutton | Chief Scientific Officer | -- | -- | -- |
| Toon Musschoot | Head of Investor Relations & Communication | -- | -- | -- |
| Mr. Kamal El Mernissi | Chief Business Development Officer | -- | -- | -- |
Biotalys NV
- Sector:
- Basic Materials
- Industry: Agricultural Inputs
Description
Biotalys NV, an agricultural technology company, discovers and develops novel biological products in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; and BIOFUN-4 targeting oomycetes in fruits and vegetables. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.
Corporate Governance
Biotalys NV’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available